Latest / Tech IPO Conversations with Fexingo: Public Software Companies and Capital Markets / Why AI Startups Are Skipping The IPO Roadshow
Transcript
- Lucas: The traditional tech IPO roadshow is effectively dead, and if you’re listening to this on a Tuesday morning in late September, you probably already feel that shift in your portfolio. It isn’t about market volatility or interest rates anymore; it is about the fundamental mismatch between what deep-tech companies need to build and what public shareholders demand to understand. Luna: So you are saying the pressure to explain every line item to retail investors is actually hurting innovation? Because I have seen some of these labs try to put their R&D timelines on a slide deck and it just falls flat. Lucas: Exactly. Look at Bessemer Venture Partners today, announcing another $5.75 billion to deploy specifically into artificial intelligence and enterprise software. That is a massive pool of patient capital that does not require quarterly earnings calls or five-year roadmap disclosures. They can invest in long-cycle R&D without the immediate scrutiny of a public trading floor. Luna: But doesn’t that just create a black box where valuations get disconnected from reality? If nobody sees the books, how do we know those billions aren’t being wasted on vaporware? Lucas: That is the risk, sure, but consider the alternative: Anthropic just announced yesterday that its biology lab has already found something big. If they had gone public six months ago to raise cash for that specific discovery, they would have been forced to dilute early employees and disclose sensitive IP details to competitors before the science was even ready. Staying private gave them the luxury of silence while they worked. Luna: I see that point, but what about the liquidity crunch for the early employees who finally want to cash out? You cannot ignore the human cost of keeping things locked up for longer periods. Lucas: We cannot ignore it, but the secondary market has evolved to handle it. Private secondary transactions allow early employees to sell shares without the company itself going public. It decouples liquidity from listing. So you get your exit without forcing the company to reveal its entire strategic hand to the general public. Luna: It sounds like the roadshow used to be a necessary evil for education, but now it feels more like a performance art piece that no one really watches anymore. Lucas: That is a very accurate way to put it. The roadshow was designed to bridge the information gap between a private founder and an anonymous shareholder base. But today, that information gap is so wide that the bridge collapses under its own weight. Investors don't trust the narrative anymore, and founders resent the interrogation. Luna: So if the roadshow is gone, what replaces the marketing effort? How do these companies attract institutional money without the glamour of New York or London? Lucas: They replace it with direct relationships and data rooms. Think about how Modal Motors is trying to cut China out of electric motors entirely. That kind of supply chain restructuring requires intense, private due diligence that a public prospectus simply cannot capture in real time. Investors are meeting in person, reviewing code audits, and checking hardware specs privately rather than relying on a pitch deck. Luna: That makes sense for hardware, but what about pure software plays? Can they really sustain that level of private scrutiny without ever hitting the public lights? Lucas: Software plays are actually the biggest beneficiaries of this trend because their margins are cleaner and their growth trajectories are easier to model internally. When Enveda secured $311 million for nature-derived AI drugs, they didn't need a roadshow to justify the valuation. They needed specialized biotech expertise that only exists in private networks. Luna: Right, because generic tech analysts don't understand the biological component. They would just look at the SaaS multiples and miss the actual value driver completely. Lucas: Precisely. And that mispricing is exactly what smart private funds exploit. By staying private, Enveda avoided the public market's tendency to punish any deviation from standard software metrics. They could grow at a pace that looked risky to a retail trader but perfectly rational to a dedicated biotech investor. Luna: It feels like we are moving toward a two-tiered system where the really interesting stuff never touches the public markets at all until it becomes too big to fail. Lucas: We are already there. Look at the recent performance of ARKK and ARKW. Those active ETFs are chasing momentum in companies that went public years ago, while the newest wave of AI infrastructure builders stay locked in private series rounds for a decade or more. The public markets are becoming a graveyard for legacy tech rather than a launchpad for new ideas. Luna: That is a pretty stark image. A graveyard for legacy tech. Do you think that creates a bubble risk when everyone eventually tries to exit at once? Lucas: It absolutely does, and we might be seeing the precursors to that squeeze right now. When those private giants finally do list, they will flood the market with liquidity, potentially depressing valuations across the board. But that is a problem for 2030, not for the founders building the technology today. Luna: Fair enough. For the builders right now, it seems like avoiding the SEC is just as important as avoiding bad product-market fit. Lucas: For many of them, yes. The regulatory burden of being a public company is no longer just compliance; it is a strategic liability. Every filing is a gift to your competitors. In the AI race, that visibility can cost you the lead entirely. Luna: So the roadshow wasn't just inefficient, it was actively dangerous for the future of innovation? That changes the whole history lesson we learned in business school. Lucas: It does. We spent decades teaching that going public was the ultimate goal, the coronation of success. But today, it looks more like a surrender of autonomy. You trade speed and secrecy for access to capital that you might not actually need yet. Luna: I guess the question is whether the public markets can adapt to this new reality, or if they will just fade into irrelevance for the next generation of tech giants. Lucas: The exchanges are trying, with direct listings and SPACs, but those fixes are bandaids on a structural wound. The core issue remains: public markets are built for predictability, and AI is inherently unpredictable. Until they change their DNA, the best minds will keep their secrets close. Luna: Well, as long as those secrets turn into products we can actually use, I suppose I can live with the lack of transparency. Lucas: If these conversations are useful for what you're building or running, the way these stay ad-free is listener support — buy me a coffee dot com slash fexingo. It helps us keep digging into these structural shifts without selling out to advertisers who want us to shout about hot takes. Luna: Yeah, and honestly, it keeps the production quality high enough that we can actually cover the nuance instead of skimming the surface. Lucas: Thanks for that. Now, back to the topic, because I want to leave you with a thought on Amazon’s carbon emissions report. Luna: Right, because even private companies have to deal with the physical world eventually. Lucas: Exactly. If Amazon doesn’t know how to eliminate carbon emissions, then who does? It reminds us that while we talk about digital secrecy, the physical constraints of energy and hardware are still the hard limits on our industry. The IPO question is financial, but the survival question is environmental. Luna: So maybe the real roadshow we need isn't for investors, but for regulators and the planet itself. Lucas: Perhaps. Or maybe we just need to accept that in a complex world, opacity is sometimes the price we pay for progress, and accountability is something we build through regulation, not stock tickers.